We are live on ! Find out more
KALA icon

KALA BIO

37 hedge funds and large institutions have $196M invested in KALA BIO in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

71% more capital inflows, than outflows

Capital inflows: $16.5M | Capital outflows: $9.7M

1.98% more ownership

Funds ownership: 67.96% → 69.94% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

3% less funds holding

Funds holding: 38 → 37 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

96% less call options, than puts

Call options by funds: $7K | Put options by funds: $197K

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.8%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
5
Increased
8
Reduced
4
Closed
6
Calls
$7K
Puts
$197K
Net Calls
-$190K
Net Calls Change
-$645K

KALA Hedge Fund Activity: Q1 2019 in Review

37 of the 4,635 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2019, worth a combined $196M — up 74% from $112M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of KALA and 5 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 8 added.

The largest buyer was Millennium Management, adding an estimated $4.8M. The largest seller was Deutsche Bank, exiting entirely with an estimated $2.13M sold.

  • 37 institutional investors held KALA BIO (KALA) as of Q1 2019, down from 38 in Q4 2018.
  • Funds reported $196M of KALA BIO stock for Q1 2019, up 74% quarter-over-quarter.
  • 5 funds opened new KALA BIO positions in Q1 2019 and 6 closed out, a net change of -1 holder.
  • The largest KALA BIO buyer in Q1 2019 was Millennium Management, an estimated $4.8M added.
  • The largest KALA BIO seller in Q1 2019 was Deutsche Bank, an estimated $2.13M sold.

Based on aggregated 13F filings for Q1 2019.